Topic: Disparities in Liver Cancer
Wednesday, April 26 | 14:00 – 16:00 local time
Focus on HCC disparities as it pertains to HCV—screening and outcomes. LD
- Title of talks to be tailored to speaker expertise and available data.
- Shared panel of both AASLD / EASL experts with engagement of audience to deliberate differences in practice paradigms between US and Europe
- Proposed 20 min talk for EASL or AASLD
PARTE 1 (60 mins)
Co-Moderator: AASLD: Juan Pablo Arab, MD
University of Western Ontario
EASL Co-Moderator: Jean Charles Nault
- Disparities in implementation of screening guidelines
(20 mins)Proposed EASL: Nathalie Ganne Carrié
- Disparities and treatment outcomes
(20 mins)AASLD: Fasiha Kanwal, MD, MSHS, AGAF, FAASLD
Michael E. DeBakey VA Medical Center
- Q&A / Panel EASL & AASLD
(20 mins)
PARTE 2 (60 mins)
Co-Moderator: AASLD: Juan Pablo Arab, MD
University of Western Ontario
EASL Co-Moderator
- HCV Screening in underserved cohorts at high risk for HCC
(20 mins)AASLD: Norah Terrault, MD, MPH, FAASLD
University of Southern California
- Impact of social determinants of health on HCC outcomes
(20 mins)Proposed EASL: Peter Jepsen
- Q&A / Joint Panel AASLD & EASL
(20 mins)
